middle.news
BlinkLab’s Autism Tech Validated in Leading Journal, Paving Way for FDA Trials
9:26am on Monday 5th of January, 2026 AEDT
•
Healthcare
Read Story
BlinkLab’s Autism Tech Validated in Leading Journal, Paving Way for FDA Trials
9:26am on Monday 5th of January, 2026 AEDT
Key Points
Peer-reviewed paper published in top-tier autism research journal
Study of 536 children confirms technology’s ability to detect sensorimotor differences
Publication strengthens clinical evidence and regulatory strategy
Follow-up paper on machine learning models underway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BLINKLAB (ASX:BB1)
OPEN ARTICLE